News & Events

News & Releases

View All News

June 2nd, 2021

ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche

VICTORIA, BRITISH COLUMBIA June 2, 2021 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development,…

May 25th, 2021

ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board

VICTORIA, BRITISH COLUMBIA May 25, 2021 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development,…

May 20th, 2021

ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing

– Demonstrating what the Company believes to be the first reported in vivo synergistic effects of a multi-antibody (3+) combination treatment – Dr. Ilse Roodink and Dr. Debby Kruijsen…